IP Library Granted Patent US 6,841,359
Granted Patent B2
US 6,841,359 · App. 10/004,381 · Granted Jan 11, 2005

Streptavidin-binding peptides and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,841,359
App. No.
10/004,381
Granted
Jan 11, 2005
Kind
B2
Abstract

The invention provides peptides with high affinity for streptavidin. These peptides may be expressed as part of fusion proteins to facilitate the detection, quantitation, and purification of proteins of interest.

Claims (24)

1. A peptide which binds streptavidin with a dissociation constant less than 10 μM and comprises an amino acid sequence having at least 80% identity to the first 38 amino acids of SEQ ID NO:25, wherein said peptide is not disulfide bonded or cyclized.

2. A peptide which binds streptavidin with a dissociation constant less than 10 μM and comprises an amino acid sequence having at least 80% identity to the first 38 amino acids of SEQ ID NO:25, wherein the amino acid sequence of said peptide does not contain an HPQ, HPM, HPN, or HQP motif.

3. A peptide which binds streptavidin with a dissociation constant less than 23 nM and comprises an amino acid sequence having at least 80% identity to the first 38 amino acids of SEQ ID NO:25.

4. The peptide of claim 1 or 2 , wherein said dissociation constant is less than 5 μM.

5. The peptide of claim 1 or 2 , wherein said dissociation constant is less than 1 μM.

6. The peptide of claim 5 , wherein said dissociation constant is less than 100 nM.

7. The peptide of claim 6 , wherein said dissociation constant is less than 50 nM.

8. The peptide of claim 3 , wherein said dissociation constant is less than 10 nM.

9. The peptide of claim 8 , wherein said dissociation constant is less than 5 nM.

10. A fusion protein comprising a protein of interest covalently linked to:

(a) a peptide which binds streptavidin with a dissociation constant less than 10 μM and comprises an amino acid sequence having at least 80% identity to the first 38 amino acids of SEQ ID NO:25, wherein said peptide is not disulfide bonded or cyclized;

(b) a peptide which binds streptavidin with a dissociation constant less than 10 μM and comprises an amino acid sequence having at least 80% identity to the first 38 amino acids of SEQ ID NO:25, wherein said peptide does not contain an HPQ, HPM, HPN, or HQP motif; or

(c) a peptide which binds streptavidin with a dissociation constant less than 23 nM and comprises an amino acid sequence having at least 80% identity to the first 38 amino acids of SEQ ID NO:25.

11. The fusion protein of claim 10 , wherein said peptide is attached to the amino terminus or the carboxy terminus of said protein of interest, or wherein said peptide is positioned between the amino and carboxy termini of said protein of interest.

12. The fusion protein of claim 10 , wherein said peptide is linked to said protein of interest by a linker comprising a protease-sensitive site.

13. The peptide of claim 1 , wherein said peptide comprises at least the first 38 amino acids of SEQ ID NO:25.

14. The peptide of claim 1 , wherein said peptide has at least 90% sequence identity to SEQ ID NO:25.

15. The peptide of claim 1 , wherein said peptide has at least 95% sequence identity to SEQ ID NO:25.

16. The peptide of claim 2 , wherein said peptide has at least 90% sequence identity to SEQ ID NO:25.

17. The peptide of claim 2 , wherein said peptide has at least 95% sequence identity to SEQ ID NO:25.

18. The peptide of claim 3 , wherein said peptide has at least 90% sequence identity to SEQ ID NO:25.

19. The peptide of claim 3 , wherein said peptide has at least 95% sequence identity to SEQ ID NO:25.

20. The peptide of claim 10 , wherein said peptide has at least 90% sequence identity to SEQ ID NO:25.

21. The peptide of claim 10 , wherein said peptide has at least 95% sequence identity to SEQ ID NO:25.

Assignments (3)
CONFIRMATORY LICENSE Recorded Oct 29, 2015
From: MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037007/0409 →
CONFIRMATORY LICENSE Recorded Aug 13, 2009
From: GENERAL HOSPITAL CORPORATION DBA MASS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023094/0257 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2004
From: SZOSTAK, JACK W.; WILSON, DAVID S.; KEEFE, ANTHONY D.
To: GENERAL HOSPITAL CORPORATION, THE
Reel/Frame 015937/0765 →